Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Schnedl, C; Fahrleitner-Pammer, A; Pietschmann, P; Amrein, K.
FGF23 in Acute and Chronic Illness.
Dis Markers. 2015; 2015(12):358086-358086
Doi: 10.1155/2015/358086
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Amrein Karin
- Schnedl Christian
- Co-Autor*innen der Med Uni Graz
- Fahrleitner-Pammer Astrid
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- FGF23 is a bone-derived phosphaturic hormone that may become a useful biomarker for the identification of high-risk patients in chronic but also acute disease. It rises early in chronic kidney disease and is strongly and independently associated with excess morbidity and mortality. Emerging data suggest that FGF23 is also elevated in different scenarios of acute illness. In this review, we give an overview on the role of this interesting disease marker and potential and proven interventional strategies and discuss a blueprint for future research.
- Find related publications in this database (using NLM MeSH Indexing)
- Animals -
- Biomarkers - blood
- Biomarkers - metabolism
- Cardiovascular Diseases - blood
- Fibroblast Growth Factors - blood
- Fibroblast Growth Factors - metabolism
- Humans -
- Renal Insufficiency, Chronic - blood
- Sepsis - blood